Braun Stacey Associates Inc Astrazeneca PLC Transaction History
Braun Stacey Associates Inc
- $2.9 Billion
- Q2 2024
A detailed history of Braun Stacey Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Braun Stacey Associates Inc holds 20,325 shares of AZN stock, worth $1.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,325
Previous 67,828
70.03%
Holding current value
$1.6 Million
Previous $4.6 Million
65.51%
% of portfolio
0.05%
Previous 0.18%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.11 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.35 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.19 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.89 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.38 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $244B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...